Press Releases on February 27, 2023 - EIN Presswire - Press Release Distribution Service

Published on February 27, 2023 - 21:05 GMT

Aveanna Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call

ATLANTA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 16, 2023, to be followed …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

SiTime to Participate at Upcoming Financial Conferences

SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the precision timing company, today announced that SiTime’s CFO, Art Chadwick, will participate at the following financial conferences. Raymond James 44th Annual …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 27, 2023 - 21:05 GMT

Adaptive Biotechnologies to Participate in the 43rd Annual Cowen Healthcare Conference

SEATTLE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 27, 2023 - 21:05 GMT

ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 Guidance

SAN CLEMENTE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2022. Fourth …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

EverQuote Announces Fourth Quarter and Full Year 2022 Financial Results

Fourth Quarter Revenue of $88.3 million Fourth Quarter Variable Marketing Margin of $29.1 million Full Year Revenue of $404.1 million Full Year Variable Marketing Margin of $128.3 million CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- EverQuote, Inc. …

Distribution channels: Business & Economy, IT Industry ...

Published on February 27, 2023 - 21:05 GMT

Astec Announces Quarterly Dividend

CHATTANOOGA, Tenn., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Astec Industries, Inc. (NASDAQ:ASTE) announced that its Board of Directors declared a quarterly dividend of $0.13 per share. The dividend is to be paid on March 30, 2023, to shareholders of record as of …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on February 27, 2023 - 21:05 GMT

Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancer

Targeting Adenosine for Cancer: Challenging Past Assumptions with Next-Generation Small Molecule Inhibitors Thursday, March 9th @ 10:30 am ET WESTPORT, Conn., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno- …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

Wish to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- ContextLogic Inc. (d/b/a Wish) (NASDAQ: WISH), one of the world’s largest mobile ecommerce platforms, today announced that its management team plans to participate in the following investor conferences in …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...

Published on February 27, 2023 - 21:05 GMT

Adverum Biotechnologies to Present at Upcoming Investor Conferences

REDWOOD CITY, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Laurent …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 27, 2023 - 21:05 GMT

Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock

DOYLESTOWN, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damage response (DDR …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

180 Degree Capital Corp. Reports Q4 2022 Results and Takes Necessary Steps to Achieve Full Business Transformation

MONTCLAIR, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180” and the “Company”), today reported its financial results as of December 31, 2022, and additional developments from the first quarter of 2023. The Company also …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 27, 2023 - 21:05 GMT

STRATA Skin Sciences Announces Regaining Compliance with NASDAQ’S Minimum Price Rule

HORSHAM, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

James River Announces Fourth Quarter And Full Year 2022 Results

PEMBROKE, Bermuda, Feb. 27, 2023 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) today reported fourth quarter 2022 net income available to common shareholders of $15.1 million ($0.40 …

Distribution channels: Business & Economy, Insurance Industry ...

Published on February 27, 2023 - 21:05 GMT

Vera Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

BRISBANE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:05 GMT

MYR Group Inc. to Attend Sidoti Investor Conference in March

THORNTON, Colo., Feb. 27, 2023 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United …

Distribution channels: Building & Construction Industry, Culture, Society & Lifestyle ...

Published on February 27, 2023 - 21:05 GMT

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 15, 2023

NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 15, 2023, short interest in 3,455 Nasdaq Global MarketSM securities totaled 9,937,951,277 shares compared with 9,983,462,569 shares in 3,463 Global Market issues …

Distribution channels: Banking, Finance & Investment Industry ...

Published on February 27, 2023 - 21:05 GMT

Clarus Reports Fourth Quarter and Full Year 2022 Results

SALT LAKE CITY, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor and consumer enthusiast markets, reported financial results for the fourth quarter and full year …

Distribution channels: Business & Economy, Sports, Fitness & Recreation ...

Published on February 27, 2023 - 21:05 GMT

Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ELX-02 for the Treatment of Alport Syndrome with ...

WATERTOWN, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that the first patients have now been dosed in its Phase 2 study of ELX- …

Distribution channels: Technology ...

Published on February 27, 2023 - 21:05 GMT

Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger

Combined company will have commercial products and a library of development candidates, two of which are clinical stage Will be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhD Lead development program will be a clinical stage therapeutic …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 27, 2023 - 21:04 GMT

TaskUs Announces Fiscal Fourth Quarter and Full Year 2022 Results

FY 2022 Revenue and Adjusted EBITDA Above Most Recent Outlook Over 26% Revenue Growth in FY 2022 Added 40 Clients in FY 2022 Number of Clients over $1 Million in Revenue Increased by 19% in FY 2022; Number of Clients over $10 Million in Revenue Increased …

Distribution channels: Business & Economy, IT Industry ...